Azatadine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Azatadine
File:Azatadine.svg
Systematic (IUPAC) name
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-
5H-benzo[5,6]cyclohepta[1,2-b]pyridine
Clinical data
Trade names Optimine
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • US: B (No risk in non-human studies)
Legal status
  • US: Withdrawn
Identifiers
CAS Number 3964-81-6 YesY
ATC code R06AX09 (WHO)
PubChem CID: 19861
IUPHAR/BPS 7119
DrugBank DB00719 YesY
ChemSpider 18709 YesY
UNII 94Z39NID6C YesY
KEGG D07482 YesY
ChEBI CHEBI:2946 YesY
ChEMBL CHEMBL946 YesY
Chemical data
Formula C20H22N2
Molecular mass 290.402 g/mol
  • n4c3\C(=C1/CCN(C)CC1)c2ccccc2CCc3ccc4
  • InChI=1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3 YesY
  • Key:SEBMTIQKRHYNIT-UHFFFAOYSA-N YesY
  (verify)

Azatadine (Optimine) is a first-generation antihistamine and anticholinergic that was launched Schering-Plough in 1973.[1][2]

It was patented in 1967.[3] It has been succeeded by other antihistamines[4]:53 and marketing approvals have been widely withdrawn.[5][6][7][8]:290[9]

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Azatadine, Villani, F. J.; Caldwell, W. U.S. Patent 3,326,924 (1967).
  4. Horak F. Antialergic and Vasoactive Drugs for Allergic Rhinitis. Chapter 4 in Allergy Frontiers:Therapy and Prevention. Volume 5 of Allergy Frontiers. Eds Pawankar R et al Springer Science & Business Media, 2010 ISBN 9784431993629
  5. Drugs.com Drugs.com listing for Azatadine Page accessed July 3, 2015
  6. Federal Register 2005 Food and Drug Administration Docket No.2005N-0058: Hospira, Inc. et al.; Withdrawal of Approval of 76 New Drug Applications and 60 Abbreviated New Drug Applications 70 FR 10651
  7. Federal Register 2007 Food and Drug Administration Docket No. 2004P-0262: Withdrawal of Approval of 128 Suitability Petitions 72 FR 8184
  8. Department of Economic and Social Affairs of the United Nations Secretariat Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or not Approved by Governments Twelfth Issue: Pharmaceuticals United Nations – New York, 2005
  9. FDA OGD Suitability Tracking Report (Sorted by Drug Name) Page accessed July 3, 2015

<templatestyles src="Asbox/styles.css"></templatestyles>